Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Ariad highlights AP-23573 product development progress over past year

Feb. 18, 2004

Xenova studies selective MRP1 inhibitors for multidrug resistance in cancer

Feb. 18, 2004

Erbitux receives FDA approval

Feb. 17, 2004

Allergan patent covers antitumor agents for breast and prostate cancer therapy

Feb. 17, 2004

Indian scientists claim new anthramycin-based antitumor agents

Feb. 17, 2004

Good safety profile reported for BBR-3576 in patients with advanced solid tumors

Feb. 17, 2004

Novel antitumor agents in early development at Zentaris

Feb. 16, 2004

Third of four phase II trials initiated for PI-88

Feb. 13, 2004

Allergan plans IND filing for Peplin's topical drug for actinic keratosis

Feb. 13, 2004

Novel DNA intercalating agent for antitumor therapy described

Feb. 13, 2004

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...